CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Plasmodium Immunotherapy for Advanced Ovarian Cancer (NCT05924776) | CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. | 2024-07-20 |
Track CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.